Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126698611 | 12669861 | 1 | I | 20100330 | 20100816 | 20160819 | 20160819 | EXP | ZA-FRI-1000015964 | FOREST | 83.90 | YR | F | Y | 45.00000 | KG | 20160819 | OT | DK | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126698611 | 12669861 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | Y | 21323 | 10 | MG | TABLET | QD | |||||
| 126698611 | 12669861 | 2 | SS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Y | 21323 | |||||||||||
| 126698611 | 12669861 | 3 | SS | RASAGILINE | RASAGILINE | 1 | Oral | Y | 0 | TABLET | QD | ||||||||
| 126698611 | 12669861 | 4 | SS | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | Oral | 300 MG | Y | 0 | 75 | MG | TABLET | QID | |||||
| 126698611 | 12669861 | 5 | SS | DURAGESIC | FENTANYL | 1 | Other | 4.1667 MCG | Y | 0 | 12.5 | UG | PATCH | ||||||
| 126698611 | 12669861 | 6 | SS | STALEVO | CARBIDOPAENTACAPONELEVODOPA | 1 | Oral | 500 MG | Y | 0 | 100 | MG | TABLET | ||||||
| 126698611 | 12669861 | 7 | C | CELEBREX | CELECOXIB | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 126698611 | 12669861 | 8 | C | IMMOVANE | 2 | Oral | 7.5 MG | 0 | 7.5 | MG | TABLET | QD | |||||||
| 126698611 | 12669861 | 9 | C | SINEMET CR | CARBIDOPALEVODOPA | 1 | Oral | 50/200 MG A DAY | 0 | TABLET | |||||||||
| 126698611 | 12669861 | 10 | C | CALCIFEROL | ERGOCALCIFEROL | 1 | 50,000 IU/MG EVERY MON/WED/FRI. | 0 | TABLET | ||||||||||
| 126698611 | 12669861 | 11 | C | OCUVITE | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126698611 | 12669861 | 1 | Depression |
| 126698611 | 12669861 | 2 | Anxiety |
| 126698611 | 12669861 | 3 | Parkinson's disease |
| 126698611 | 12669861 | 4 | Osteoarthritis |
| 126698611 | 12669861 | 5 | Osteoarthritis |
| 126698611 | 12669861 | 6 | Parkinson's disease |
| 126698611 | 12669861 | 7 | Osteoarthritis |
| 126698611 | 12669861 | 8 | Insomnia |
| 126698611 | 12669861 | 9 | Parkinson's disease |
| 126698611 | 12669861 | 10 | Osteoporosis |
| 126698611 | 12669861 | 11 | Macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126698611 | 12669861 | HO |
| 126698611 | 12669861 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126698611 | 12669861 | Dyskinesia | |
| 126698611 | 12669861 | Hyperhidrosis | |
| 126698611 | 12669861 | Hyperkalaemia | |
| 126698611 | 12669861 | Hypertension | |
| 126698611 | 12669861 | Psychotic disorder | |
| 126698611 | 12669861 | Pyrexia | |
| 126698611 | 12669861 | Renal failure | |
| 126698611 | 12669861 | Rhabdomyolysis | |
| 126698611 | 12669861 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126698611 | 12669861 | 1 | 200811 | 20100403 | 0 | |
| 126698611 | 12669861 | 3 | 201001 | 20100401 | 0 | |
| 126698611 | 12669861 | 4 | 200901 | 20100403 | 0 | |
| 126698611 | 12669861 | 5 | 20100402 | 0 | ||
| 126698611 | 12669861 | 6 | 201001 | 20100403 | 0 | |
| 126698611 | 12669861 | 7 | 201002 | 20100403 | 0 | |
| 126698611 | 12669861 | 8 | 200811 | 20100403 | 0 | |
| 126698611 | 12669861 | 10 | 200811 | 0 |